Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer
JAMA
.
2017 Feb 7;317(5):531-534.
doi: 10.1001/jama.2016.16918.
Authors
Allison W Kurian
1
,
Kent A Griffith
2
,
Ann S Hamilton
3
,
Kevin C Ward
4
,
Monica Morrow
5
,
Steven J Katz
6
,
Reshma Jagsi
7
Affiliations
1
Stanford University, Department of Medicine, Stanford, California.
2
University of Michigan, Department of Biostatistics, Ann Arbor.
3
University of Southern California, Department of Preventive Medicine, Los Angeles.
4
Emory University, Department of Epidemiology, Atlanta, Georgia.
5
Memorial Sloan-Kettering Cancer Center, Department of Surgery, New York, New York.
6
University of Michigan, Department of Internal Medicine, Ann Arbor.
7
University of Michigan, Department of Radiation Oncology, Ann Arbor.
PMID:
28170472
PMCID:
PMC5530866
DOI:
10.1001/jama.2016.16918
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms / diagnosis
Counseling
Genes, BRCA1
Genes, BRCA2*
Genetic Counseling / psychology
Genetic Predisposition to Disease
Genetic Testing*
Humans
Grants and funding
HHSN261201000140C/CA/NCI NIH HHS/United States
HHSN261201000035C/CA/NCI NIH HHS/United States
HHSN261201000035I/CA/NCI NIH HHS/United States
HHSN261201300015C/CA/NCI NIH HHS/United States
HHSN261201000034C/CA/NCI NIH HHS/United States
U58 DP003862/DP/NCCDPHP CDC HHS/United States
P30 CA046592/CA/NCI NIH HHS/United States
5NU58DP003862/CC/CDC HHS/United States
P01 CA163233/CA/NCI NIH HHS/United States
U58 DP003875/DP/NCCDPHP CDC HHS/United States